Professor at University of Lille since 2002; head of General and Endocrine Surgery at Lille University Hospital since 2005; Director of INSERM U1190.
More than 400 peer-reviewed articles; research spans cell therapy for type 1 diabetes and metabolic surgery for type 2 diabetes and obesity-related disease.